The incidence of retinopathy of prematurity (ROP) continues to rise due to the improved
survival of very low birth weight infants in developed countries. This epidemic is also fueled …

Topic To compare bevacizumab, ranibizumab, aflibercept, and laser treatment as primary
therapies for retinopathy of prematurity (ROP) in terms of retreatment rate. Clinical relevance …

Background Despite increasing worldwide use of anti-vascular endothelial growth factor
agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular …

Retinopathy of prematurity (ROP) is among the most common causes of childhood
blindness. Three phases of ROP epidemics have been observed worldwide since ROP was …

OBJECTIVE: Among extremely preterm infants, we evaluated whether bevacizumab therapy
compared with surgery for retinopathy of prematurity (ROP) is associated with adverse …

BACKGROUND Endometriosis is a benign gynaecological disorder, which affects 10% of
reproductive-aged women and is characterized by endometrial cells from the lining of the …

Retinopathy of prematurity (ROP) is a rare proliferative ocular disorder in preterm infants.
Because of the advancements in neonatal care, the incidence of ROP has increased …

Endothelial cells play a major part in the regulation of vascular permeability and
angiogenesis. According to their duty to fit the needs of the underlying tissue, endothelial …

BACKGROUND Nanotechnology involves the engineering of structures on a molecular
level. Nanomedicine and nano-delivery systems have been designed to deliver therapeutic …

Angiogenesis is required in cancer, including gynecological cancers, for the growth of
primary tumors and secondary metastases. Development of anti-angiogenesis therapy in …